Pregled bibliografske jedinice broj: 1133533
A Dry Powder Platform for Nose-to-Brain Delivery of Dexamethasone: Formulation Development and Nasal Deposition Studies
A Dry Powder Platform for Nose-to-Brain Delivery of Dexamethasone: Formulation Development and Nasal Deposition Studies // Pharmaceutics, 13 (2021), 6; 795, 30 doi:10.3390/pharmaceutics13060795 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1133533 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
A Dry Powder Platform for Nose-to-Brain Delivery
of Dexamethasone: Formulation Development and
Nasal Deposition Studies
Autori
Nižić Nodilo, Laura ; Ugrina, Ivo ; Špoljarić, Drago ; Amidžić Klarić, Daniela ; Jakobušić Brala, Cvijeta ; Perkušić, Mirna ; Pepić, Ivan ; Lovrić, Jasmina ; Saršon, Vesna ; Safundžić Kučuk, Maša ; Zadravec, Dijana ; Kalogjera, Livije ; Hafner, Anita
Izvornik
Pharmaceutics (1999-4923) 13
(2021), 6;
795, 30
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
dexamethasone sodium phosphate ; nose-to-brain delivery ; spray-dried microspheres ; pectin ; hypromellose ; mannitol ; 3D nasal cavity model ; in vitro nasal deposition
Sažetak
Nasal route of administration offers a unique opportunity of brain targeted drug delivery via olfactory and trigeminal pathway, providing effective CNS concentrations at lower doses and lower risk for adverse reactions compared to systemic drug administration. Therefore, it has been recently proposed as a route of choice for glucocorticoids to control neuroinflammation processes in patients with severe Covid-19. However, appropriate delivery systems tailored to enhance their efficacy yet need to emerge. In this work we present the development of sprayable brain targeting powder delivery platform of dexamethasone sodium phosphate (DSP). DSP-loaded microspheres, optimised employing Quality-by- Design approach, were blended with soluble inert carriers (mannitol or lactose monohydrate). Powder blends were characterized in terms of homogeneity, flow properties, sprayability, in vitro biocompatibility, permeability and mucoadhesion. Nasal deposition studies were performed using 3D printed nasal cavity model. Mannitol provided better powder blend flow properties compared to lactose. Microspheres blended with mannitol retained or enlarged their mucoadhesive properties and enhanced DSP permeability across epithelial model barrier. DSP dose fraction deposited in the olfactory region reached 17.0% revealing the potential of developed powder platform for targeted olfactory delivery. The observed impact of nasal cavity asymmetry highlighted the importance of individual approach when aiming olfactory region.
Izvorni jezik
Engleski
Znanstvena područja
Farmacija
POVEZANOST RADA
Projekti:
HRZZ-UIP-2017-05-4592 - Optimiranje depozicije raspršenih in situ gelirajućih i praškastih terapijskih sustava u nosnoj šupljini (OptiNasalSpray) (Hafner, Anita, HRZZ - 2017-05) ( CroRIS)
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Stomatološki fakultet, Zagreb,
Medicinski fakultet, Zagreb,
KBC "Sestre Milosrdnice",
Prirodoslovno-matematički fakultet, Split
Profili:
Dijana Zadravec
(autor)
Anita Hafner
(autor)
Livije Kalogjera
(autor)
Ivan Pepić
(autor)
Daniela Amidžić Klarić
(autor)
Laura Nižić Nodilo
(autor)
Mirna Perkušić
(autor)
Ivo Ugrina
(autor)
Maša Safundžić Kučuk
(autor)
Jasmina Lovrić
(autor)
Drago Špoljarić
(autor)
Cvijeta Jakobušić Brala
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE